From harm reduction to drug user abstinence: a journey in drug treatment policy

2011 ◽  
Vol 16 (3) ◽  
pp. 179-194 ◽  
Author(s):  
Neil McKeganey
Keyword(s):  
Drug Treatment ◽  
Harm Reduction ◽  
Drug User ◽  
Treatment Policy

scholarly journals Triangulating Syndemic Services and Drug Treatment Policy: Improving Drug Treatment Portal Locations in Baltimore City

2016 ◽  
Vol 10 (2) ◽  
pp. 319-327 ◽  
Author(s):  
C. Debra M. Furr-Holden ◽  
Adam J. Milam ◽  
Elizabeth D. Nesoff ◽  
Joshua Garoon ◽  
Mieka J. Smart ◽  
...  
Keyword(s):  
Drug Treatment ◽  
Baltimore City ◽  
Treatment Policy

Narcan as biomedical panic: The war on overdose and the harms of harm reduction

2020 ◽  
pp. 136248062096477
Author(s):  
Philip R Kavanaugh
Keyword(s):  
Public Health ◽  
Drug Treatment ◽  
Harm Reduction ◽  
Drug Users ◽  
Opioid Addiction ◽  
The State ◽  
Opioid Overdose ◽  
State Response ◽  
Drug Companies ◽  
The Us

As the opioid overdose crisis in the US persists, governments have coordinated with drug companies to propagate the overdose reversal drug naloxone (Narcan) as a ‘kinder/gentler’ state response, deriving from a supposedly progressive harm reduction ethos. Drawing on Derrida’s deconstruction of pharmakon, I show how Narcan is rendered paradoxical and terminal, diverting attention from the structural antecedents of opioid addiction and resources for drug treatment while reproducing corporeal suffering in those revived. I further highlight how Narcan is positioned in a wider array of regressive governing practices that legitimate the state’s punitive drug war and demonization of drug users. Narcan thus provides a useful opening between the state and contemporary biomedicine to theorize how harm reduction and public health unfurl in insidious and corrosive ways.

Alcohol and other drug treatment policy in Australia

2016 ◽  
Vol 204 (4) ◽  
pp. 138-138 ◽  
Author(s):  
Alison Ritter ◽  
Mark Stoove
Keyword(s):  
Drug Treatment ◽  
Treatment Policy

DRUG TREATMENT POLICY

The Lancet ◽  
1987 ◽  
Vol 329 (8534) ◽  
pp. 692
Author(s):  
R. Batey
Keyword(s):  
Drug Treatment ◽  
Treatment Policy

scholarly journals Prison-based drug treatment in Finland: History, shifts in policy making and current status

2012 ◽  
Vol 29 (6) ◽  
pp. 575-588 ◽  
Author(s):  
Jouni Tourunen ◽  
Antti Weckroth ◽  
Teemu Kaskela
Keyword(s):  
Drug Treatment ◽  
Harm Reduction ◽  
Criminal Policy ◽  
Healthcare Services ◽  
Current Status ◽  
Individual Risk ◽  
Rehabilitative Treatment ◽  
National Drug ◽  
Free Environment ◽  
Abuse Treatment

Aim The article outlines, at the level of political discourse, changes in drug and criminal policy that may have influenced the penal system as a backdrop to the rise of prison-based drug treatment programmes (PBDT) in Finland. Methods and Data Our perspective is historical. The article is based on historical and political documents, scholarly research and white papers. Results The history of PBDT in Finland is characterised by an absence of drug treatment programmes until the 1980s, first initiatives at the end of the 1980s, enthusiastic programme development from the mid-1990s, and decreasing interest during recent years. Unlike the National Drug Strategy, the Prison Drug Strategy aimed at a drug-free environment (zero tolerance) and implemented harm-reduction measures only to a limited extent. Conclusion The development of PBDT represents the new way of performing treatment in prisons, with features of managerialism. PBDT is also affected by an organisational segregation of rehabilitation and medical treatment, which prevents integration of harm-reduction measures with rehabilitative treatment, and is in conflict with general aims of integrating substance abuse treatment to mental and healthcare services in Finland. In the spirit of a new kind of Penal Welfarism, the role of documented individual risk and needs assessment in defining an offender's sentence has increased.

Sign in / Sign up

Export Citation Format

Share Document